LITFULO 50mg capsules medication leaflet

L04AF08 ritlecitinib • Antineoplastic and immunomodulating agents | Immunosuppressants | Janus-associated kinase (JAK) inhibitors

Ritlecitinib is a medication used to treat certain autoimmune conditions, such as alopecia areata, a disease that causes patchy hair loss on the scalp or body. This medicine works by inhibiting enzymes involved in the inflammatory process, thereby reducing the autoimmune reaction that affects hair follicles. Ritlecitinib can help stop hair loss and stimulate regrowth.

Ritlecitinib is usually administered as tablets, according to the specialist’s instructions. The dose and duration of treatment are determined individually, based on the severity of the disease and the patient’s response to therapy. It is important to take the medication regularly and not to stop treatment without medical advice.

Side effects may include upper respiratory tract infections, headaches, nausea, diarrhea, or increased values in some blood tests. In rare cases, allergic reactions or more severe infections may occur. If unusual or severe symptoms appear, it is recommended to contact your doctor immediately.

Ritlecitinib offers a new option for patients with alopecia areata or other autoimmune diseases, helping to improve quality of life. Careful monitoring and constant communication with the medical team are essential for the safety and effectiveness of the treatment.

General data about LITFULO 50mg

Substance: ritlecitinib

Commercial code: W71229001

Concentration: 50mg

Pharmaceutical form: capsules

Quantity: 10

Product type: generic

Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer: PFIZER MANUFACTURING DEUTSCHLAND GMBH - GERMANIA

Holder: PFIZER EUROPE MA EEIG - BELGIA

Number: 1755/2023/01

Shelf life: 3 years

Other substances similar to ritlecitinib